Plunkett Research Online: Astellas Gene Therapies

ASTELLAS GENE THERAPIES (Subsidiary) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Astellas Gene Therapies is a biotechnology company that develops genetic medicines. The firm’s investigational therapies target rare diseases through three modalities: gene replacement, exon skipping gene therapy and vectorized ribonucleic acid (RNA) knockdown. Astellas’ current innovative therapi.....


ASTELLAS GENE THERAPIES

Ticker: Subsidiary
Exchange:
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 415-818-1001
Fax:
Address: 600 California St., Fl. 17
San Francisco, CA 94108 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:
Parent Company: Astellas Pharma Inc

Contacts Description

Kenji YasukawaCEO/Pres.
Thomas SolowayCFO/Chief Accounting Officer/Executive VP
See More
Astellas Gene Therapies is a biotechnology company that develops genetic medicines. The firm’s investigational therapies target rare diseases through three modalities: gene replacement, exon skipping gene therapy and vectorized ribonucleic acid (RNA) knockdown. Astellas’ current innovative therapi.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture